Advice given to patients with fracturesBMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7199.1698 (Published 19 June 1999) Cite this as: BMJ 1999;318:1698
Drug treatments that reduce fracture rate are underused after vertebral fractures
- David J Torgerson, Senior research fellow (email@example.com),
- Paul Dolan, Senior lecturer in economics
- Centre for Health Economics, University of York, York YO10 5DD
- Sheffield Health Economics Group and Department of Economics, University of Sheffield, Sheffield S1 4DA
- Department of Medicine, Addenbrooke's Hospital, Cambridge CB2 2QQ
EDITOR—We recently undertook a cost analysis of osteoporosis, which showed that the disease is probably more costly than earlier estimates quoted by Pal suggested.1 We estimated that the total annual cost of fractures in a United Kingdom population is around £940 million, with hip fractures costing roughly £12 000 each.2 More importantly, using data from the general practice research database, like Pal we found little evidence that patients who had sustained a fracture were being offered treatment.3 The table (taken from our paper) summarises our results.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial